REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • March 4th, 2021 • Molecular Data Inc. • Services-business services, nec • New York
THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of March 3, 2021 (the “Execution Date”), is entered into by and between Molecular Data Inc., a Cayman Islands corporation (the “Company”), and White Lion Capital, LLC, a Nevada limited liability company (together with it permitted assigns, the “Buyer”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Ordinary Share Purchase Agreement by and between the parties hereto, dated as of the Execution Date (as amended, restated, supplemented or otherwise modified from time to time, the “Purchase Agreement”).
INDEMNIFICATION AGREEMENTIndemnification Agreement • December 6th, 2019 • Molecular Data Inc. • Services-business services, nec
THIS INDEMNIFICATION AGREEMENT (this “Agreement”) is made as of , 2019 by and between Molecular Data Inc., an exempted company incorporated and existing under the laws of the Cayman Islands (the “Company”), and (Passport/ID Card No. ) (the “Indemnitee”).
EMPLOYMENT AGREEMENTEmployment Agreement • December 6th, 2019 • Molecular Data Inc. • Services-business services, nec • New York
This EMPLOYMENT AGREEMENT (the “Agreement”) is entered into as of , 2019 by and between Molecular Data Inc., an exempted company incorporated and existing under the laws of the Cayman Islands (the “Company”) and (Passport/PRC ID Card No.: ) (the “Executive”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • April 13th, 2021 • Molecular Data Inc. • Services-business services, nec • Utah
THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of April 7, 2021, by and among MOLECULAR DATA INC., a company formed and existing under the laws of the Cayman Islands (the “Company”), and Streeterville Capital, LLC, a Utah limited liability company (the “Investor”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 13th, 2020 • Molecular Data Inc. • Services-business services, nec • New York
THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of October 9 , 2020, is between MOLECULAR DATA INC., a company incorporated under the laws of the Cayman Islands, with principal executive offices located at 5/F, Building 12, 1001 North Qinzhou Road, Xuhui District, Shanghai 201109, Peoples Republic of China (the “Company”), and each of the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively the “Buyers”).
34,500,000 Shares MOLECULAR DATA INC. CLASS A ORDINARY SHARES, PAR VALUE US$0.00005 PER SHARE IN THE FORM OF AMERICAN DEPOSITARY SHARES UNDERWRITING AGREEMENTUnderwriting Agreement • December 20th, 2019 • Molecular Data Inc. • Services-business services, nec • New York
Molecular Data Inc., an exempted company incorporated with limited liability under the laws of the Cayman Islands (the “Company”), proposes to issue and sell to the several Underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of 34,500,000 Class A ordinary shares, par value US$0.00005 per share, of the Company (the “Firm Shares”) in the form of 11,500,000 American Depositary Shares (as defined below).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 17th, 2021 • Molecular Data Inc. • Services-business services, nec • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of September 15, 2021, between Molecular Data Inc., a company incorporated under the laws of the Cayman Islands (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
Shareholders’ Voting Rights Proxy AgreementShareholders’ Voting Rights Proxy Agreement • December 6th, 2019 • Molecular Data Inc. • Services-business services, nec • Shanghai
This Shareholders’ Voting Rights Proxy Agreement (the “Agreement”) is entered into by and between the following parties on December 21, 2018 in Shanghai, the People’s Republic of China (the “PRC”):
Exclusive Option AgreementExclusive Option Agreement • December 6th, 2019 • Molecular Data Inc. • Services-business services, nec • Shanghai
This Exclusive Option Agreement (the “Agreement”) is entered into by and between the following parties on December 21, 2018 in Shanghai, the People’s Republic of China (the “PRC”):
Exclusive Technical Support and Service AgreementSupport and Service Agreement • December 6th, 2019 • Molecular Data Inc. • Services-business services, nec • Shanghai
This Exclusive Technical Support and Service Agreement (the “Agreement”) is entered into by and between the following parties on December 21, 2018 in Shanghai, the People’s Republic of China (the “PRC”):
ORDINARY SHARE PURCHASE AGREEMENTOrdinary Share Purchase Agreement • March 4th, 2021 • Molecular Data Inc. • Services-business services, nec • California
This Ordinary Share Purchase Agreement is entered into effective as of this 3rd day of March, 2021 (this “Agreement”), by and between MOLECULAR DATA INC., a Cayman Islands corporation (the “Company”), and WHITE LION CAPITAL LLC, a Nevada limited liability company (the “Investor”).
PRE-FUNDED WARRANT TO PURCHASE CLASS A ORDINARY SHARES REPRESENTED BY AMERICAN DEPOSITARY SHARES MOLECULAR DATA INC.Molecular Data Inc. • September 17th, 2021 • Services-business services, nec • New York
THIS PRE-FUNDED WARRANT TO PURCHASE CLASS A ORDINARY SHARES REPRESENTED BY AMERICAN DEPOSITARY SHARES (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) until this Warrant is exercised in full (the “Termination Date”), to subscribe for and purchase from Molecular Data Inc., an exempted company formed under the laws of the Cayman Islands (the “Company”), up to ______ Class A Ordinary Shares, par value US $0.00005 (the “Class A Ordinary Share(s)”) (as subject to adjustment hereunder, the “Warrant Shares”)), represented by _____________ American Depositary Share (“ADSs”), each 3 Class A Ordinary Shares representing one ADS, as subject to adjustment hereunder (the “Warrant ADSs”). The purchase price of one Warrant ADS shall be equal to the Exercise Price, as defined
Equity Pledge AgreementEquity Pledge Agreement • December 6th, 2019 • Molecular Data Inc. • Services-business services, nec
This Equity Pledge Agreement (the “Agreement”) is entered into by and between the following parties on December 21, 2018 in Shanghai, the People’s Republic of China (the “PRC”):
PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • September 17th, 2021 • Molecular Data Inc. • Services-business services, nec • New York
Introduction. Subject to the terms and conditions herein (this “Agreement”), Molecular Data Inc. (the “Company”), hereby agrees to sell up to approximately $15,000,000 of securities of the Company directly to accredited investors (each, an “Investor” and collectively, the “Investors”) through Aegis Capital Corp., as placement agent (the “Placement Agent).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 13th, 2021 • Molecular Data Inc. • Services-business services, nec • Utah
THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of April 7, 2021, is between MOLECULAR DATA INC., a company incorporated under the laws of the Cayman Islands, with principal executive offices located at11/F, Building 15, 2177 Shenkun Road Minhang District, Shanghai 201106, Peoples Republic of China (the “Company”), and each of the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively the “Buyers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 14th, 2021 • Molecular Data Inc. • Services-business services, nec • New York
THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of July 14, 2021, is between MOLECULAR DATA INC., a company incorporated under the laws of the Cayman Islands, with principal executive offices located at 5/F, Building 12, 1001 North Qinzhou Road, Xuhui District, Shanghai 201109, Peoples Republic of China (the “Company”), the investors listed on the Schedule of Buyers attached hereto (the “Buyer”).
PURCHASE WARRANT TO PURCHASE CLASS A ORDINARY SHARES REPRESENTED BY AMERICAN DEPOSITARY SHARES MOLECULAR DATA INC.Purchase Warrant • September 17th, 2021 • Molecular Data Inc. • Services-business services, nec • New York
THIS WARRANT TO PURCHASE CLASS A ORDINARY SHARES REPRESENTED BY AMERICAN DEPOSITARY SHARES (the “Warrant”) certifies that, for value received, _________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on September 16, 2026 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Molecular Data, Inc., an exempted company formed under the laws of the Cayman Islands (the “Company”), up to _______ Class A Ordinary Shares, par value US $0.00005 (the “Class A Ordinary Share(s)”) (as subject to adjustment hereunder, the “Warrant Shares”), represented by _____________ American Depositary Share (“ADSs”), each 3 Class A Ordinary Shares representing one ADS, as subject to adjustment hereunder (the ADSs issuable hereunder, the “Warrant ADSs”). The purchase price o
EQUITY PURCHASE AGREEMENTEquity Purchase Agreement • May 25th, 2021 • Molecular Data Inc. • Services-business services, nec • New York
THIS EQUITY PURCHASE AGREEMENT (this "Agreement") is entered into as of 13 May, 2021 (the "Execution Date"), by and between Molecular Data Inc., a company incorporated under the laws of the Cayman Islands (the "Company"), and Oasis Capital, LLC, a Puerto Rico limited liability company (the "Investor").
